Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized, double blind, placebo controlled study of DG-041 in peripheral arterial disease
2006-001368-22Phase 2Completed
- Sponsor
- deCODE genetics ehf.
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in arteriosclerosis obliterans comparing DG-041 with Placebo (2 arms). Started Apr 2006; status: completed.
02
Drugs
DG041
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on 2006-001368-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001368-22.